Acute and Chronic Therapeutic Impact of a Vasopressin 2 Antagonist (Tolvaptan) in Congestive Heart Failure (ACTIV in CHF): A multicenter, randomized trial in patients hospitalized with worsening heart failure
Publication
, Journal Article
Gheorghiade, M; O'Connor, C; Adams, K; Gattis, W; Barbagelata, NA; Elkayam, U; McGrew, F; Ghai, J; Benza, R; Klaphoiz, M; Orlandi, C ...
Published in: JAMA
2004
Duke Scholars
Published In
JAMA
Publication Date
2004
Volume
291
Start / End Page
1961 / 1971
Citation
APA
Chicago
ICMJE
MLA
NLM
Gheorghiade, M., O’Connor, C., Adams, K., Gattis, W., Barbagelata, N. A., Elkayam, U., … ACTIV Trial Investigators, . (2004). Acute and Chronic Therapeutic Impact of a Vasopressin 2 Antagonist (Tolvaptan) in Congestive Heart Failure (ACTIV in CHF): A multicenter, randomized trial in patients hospitalized with worsening heart failure. JAMA, 291, 1961–1971.
Gheorghiade, M., C. O’Connor, K. Adams, W. Gattis, N. A. Barbagelata, U. Elkayam, F. McGrew, et al. “Acute and Chronic Therapeutic Impact of a Vasopressin 2 Antagonist (Tolvaptan) in Congestive Heart Failure (ACTIV in CHF): A multicenter, randomized trial in patients hospitalized with worsening heart failure.” JAMA 291 (2004): 1961–71.
Gheorghiade M, O’Connor C, Adams K, Gattis W, Barbagelata NA, Elkayam U, et al. Acute and Chronic Therapeutic Impact of a Vasopressin 2 Antagonist (Tolvaptan) in Congestive Heart Failure (ACTIV in CHF): A multicenter, randomized trial in patients hospitalized with worsening heart failure. JAMA. 2004;291:1961–71.
Gheorghiade, M., et al. “Acute and Chronic Therapeutic Impact of a Vasopressin 2 Antagonist (Tolvaptan) in Congestive Heart Failure (ACTIV in CHF): A multicenter, randomized trial in patients hospitalized with worsening heart failure.” JAMA, vol. 291, 2004, pp. 1961–71.
Gheorghiade M, O’Connor C, Adams K, Gattis W, Barbagelata NA, Elkayam U, McGrew F, Ghai J, Benza R, Klaphoiz M, Orlandi C, ACTIV Trial Investigators. Acute and Chronic Therapeutic Impact of a Vasopressin 2 Antagonist (Tolvaptan) in Congestive Heart Failure (ACTIV in CHF): A multicenter, randomized trial in patients hospitalized with worsening heart failure. JAMA. 2004;291:1961–1971.
Published In
JAMA
Publication Date
2004
Volume
291
Start / End Page
1961 / 1971